KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to $952000.0.

  • Arbutus Biopharma's Interest & Investment Income fell 4550.66% to $952000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year decrease of 2931.98%. This contributed to the annual value of $6.6 million for FY2024, which is 1577.0% up from last year.
  • Latest data reveals that Arbutus Biopharma reported Interest & Investment Income of $952000.0 as of Q3 2025, which was down 4550.66% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Arbutus Biopharma's Interest & Investment Income peaked at $1.8 million during Q2 2024, and registered a low of $27000.0 during Q3 2021.
  • For the 5-year period, Arbutus Biopharma's Interest & Investment Income averaged around $935947.4, with its median value being $1.0 million (2025).
  • As far as peak fluctuations go, Arbutus Biopharma's Interest & Investment Income tumbled by 8869.57% in 2021, and later skyrocketed by 304333.33% in 2022.
  • Arbutus Biopharma's Interest & Investment Income (Quarter) stood at $30000.0 in 2021, then skyrocketed by 3043.33% to $943000.0 in 2022, then surged by 55.36% to $1.5 million in 2023, then fell by 0.07% to $1.5 million in 2024, then plummeted by 34.97% to $952000.0 in 2025.
  • Its Interest & Investment Income was $952000.0 in Q3 2025, compared to $1.0 million in Q2 2025 and $1.2 million in Q1 2025.